Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in people with bipolar depression.

Trial Profile

Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in people with bipolar depression.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jan 2014

At a glance

  • Drugs Lamotrigine (Primary) ; Folic acid; Quetiapine
  • Indications Bipolar I disorders; Bipolar II disorders
  • Focus Therapeutic Use
  • Acronyms CEQUEL
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 30 Jan 2014 According to UKCRN record accrual to date is 89%
    • 23 Dec 2013 Planned number of patients changed from 584 to 202 as reported by ISRCTN.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top